scispace - formally typeset
C

Chang Ok Suh

Researcher at Yonsei University

Publications -  259
Citations -  5471

Chang Ok Suh is an academic researcher from Yonsei University. The author has contributed to research in topics: Radiation therapy & Breast cancer. The author has an hindex of 35, co-authored 251 publications receiving 4634 citations. Previous affiliations of Chang Ok Suh include University Health System & Dong-a University.

Papers
More filters
Journal ArticleDOI

Dose-response relationship in local radiotherapy for hepatocellular carcinoma

TL;DR: The results of this study showed that 3D-CRT can theoretically be used for treating primary HCC and that only the radiation dose was a significant factor for predicting an objective response.
Journal ArticleDOI

Angiocentric Lymphoma of the Head and Neck: Patterns of Systemic Failure After Radiation Treatment

TL;DR: Treatment with radiation alone had suboptimal results, partly because of the occurrence of a variety of systemic failure with diverse clinicopathologic features, and it is believed that the multimodality treatment approach containing more effective chemotherapeutic agents should be incorporated in the treatment of angiocentric lymphoma confined to the head and neck.
Journal Article

Dose Response Relationship in Local Radiotherapy for Hepatocellular Carcinoma.

TL;DR: In this article, the authors showed the existence of a dose-response relationship in local radiotherapy for primary hepatocellular carcinoma (HCC) for primary HCC patients.
Journal ArticleDOI

Combined transcatheter arterial chemoembolization and local radiotherapy of unresectable hepatocellular carcinoma.

TL;DR: Combined TACE and local RT is feasible and tolerable and would be a new promising modality in unresectable HCC, and further study is required to compare the therapeutic efficacy to TACE alone.
Journal ArticleDOI

Local radiotherapy as a complement to incomplete transcatheter arterial chemoembolization in locally advanced hepatocellular carcinoma.

TL;DR: The treatment results of patients receiving TACE plus RT were analyzed and compared with those treated with TACE alone, to determine the effect of additional radiotherapy after an incomplete transcatheter arterial chemoembolization in an unresectable hepatocellular carcinoma.